Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered T-cells for adoptive immunotherapy.

Martin Pule1, Catherine M Bollard, Helen E Heslop

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.

Current Opinion in Molecular Therapeutics
|November 19, 2002
PubMed
Summary

Adaptive immunotherapy using genetically modified T-cells shows promise for treating cancers and viral infections. Research focuses on enhancing T-cell targeting and resistance to tumor evasion for improved therapeutic outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Nature medicine·2026
Same author

A reassessment of anti-CAR T-cell expansion strategies.

Blood·2026
Same author

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same author

Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.

Transplantation and cellular therapy·2026
Same author

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.

Neuro-oncology advances·2026

Area of Science:

  • Immunology
  • Oncology
  • Gene Therapy

Background:

  • Adaptive immunotherapy with T-cells is a developing treatment for malignancies and viral infections.
  • Genetic modification of T-cells is established for tracking, immune response redirection, and safety ablation.
  • Tumor evasion remains a challenge for T-cell therapies.

Purpose of the Study:

  • To explore novel strategies for targeting T-cells to tumors.
  • To genetically modify T-cells for enhanced tumor targeting and resistance to evasion.
  • To evaluate these strategies in preclinical models.

Main Methods:

  • Genetic engineering of T-cells.
  • Development of T-cell homing mechanisms to tumors.
  • Preclinical testing of modified T-cells against tumor models.

Related Experiment Videos

Main Results:

  • Preclinical models are being used to evaluate new strategies.
  • Focus on improving T-cell delivery and function within the tumor microenvironment.
  • Investigating methods to overcome tumor-induced immunosuppression.

Conclusions:

  • Advanced genetic modification techniques are crucial for effective T-cell therapy.
  • Overcoming tumor evasion mechanisms is key to successful adaptive immunotherapy.
  • Preclinical evaluations are essential for advancing T-cell-based cancer treatments.